Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’
PositiveFinancial Markets

Mark Cuban believes that Donald Trump's new drug platform has the potential to succeed, especially if it prompts pharmaceutical managers to make necessary changes. Cuban, who founded Cost Plus Drugs in 2022 to offer discounted pharmaceuticals directly to consumers, sees this as a significant opportunity for reform in the industry. If Trump's initiative leads to real improvements, he suggests that Trump would deserve the credit for driving that change, highlighting the importance of accountability in healthcare.
— Curated by the World Pulse Now AI Editorial System